184 related articles for article (PubMed ID: 31242931)
1. Multicentre Randomised trial of Acute Stroke treatment in the Ambulance with a nitroglycerin Patch (MR ASAP): study protocol for a randomised controlled trial.
van den Berg SA; Dippel DWJ; Hofmeijer J; Fransen PSS; Caminada K; Siegers A; Kruyt ND; Kerkhoff H; de Leeuw FE; Nederkoorn PJ; van der Worp HB;
Trials; 2019 Jun; 20(1):383. PubMed ID: 31242931
[TBL] [Abstract][Full Text] [Related]
2. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
van den Berg SA; Uniken Venema SM; Reinink H; Hofmeijer J; Schonewille WJ; Miedema I; Fransen PSS; O Pruissen DM; Raaijmakers TWM; van Dijk GW; de Leeuw FE; van Vliet JA; Kwa VIH; Kerkhoff H; van 't Net A; Boomars R; Siegers A; Lok T; Caminada K; Esteve Cuevas LM; Visser MC; Zwetsloot CP; Boomsma JMF; Schipper MH; van Eijkelenburg RPJ; Berkhemer OA; Nieboer D; Lingsma HF; Emmer BJ; van Oostenbrugge RJ; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Nederkoorn PJ; van der Worp HB;
Lancet Neurol; 2022 Nov; 21(11):971-981. PubMed ID: 36058230
[TBL] [Abstract][Full Text] [Related]
3. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.
RIGHT-2 Investigators
Lancet; 2019 Mar; 393(10175):1009-1020. PubMed ID: 30738649
[TBL] [Abstract][Full Text] [Related]
4. Pre-hospital transdermal glyceryl trinitrate in patients with stroke mimics: data from the RIGHT-2 randomised-controlled ambulance trial.
Tunnage B; Woodhouse LJ; Dixon M; Anderson C; Ankolekar S; Appleton J; Cala L; England T; Krishnan K; Havard D; Mair G; Muir K; Phillips S; Potter J; Price C; Randall M; Robinson TG; Roffe C; Sandset E; Siriwardena N; Scutt P; Wardlaw JM; Sprigg N; Bath PM;
BMC Emerg Med; 2022 Jan; 22(1):2. PubMed ID: 35012462
[TBL] [Abstract][Full Text] [Related]
5. Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).
Appleton JP; Scutt P; Dixon M; Howard H; Haywood L; Havard D; Hepburn T; England T; Sprigg N; Woodhouse LJ; Wardlaw JM; Montgomery AA; Pocock S; Bath PM;
Int J Stroke; 2019 Feb; 14(2):191-206. PubMed ID: 28762896
[TBL] [Abstract][Full Text] [Related]
6. Prehospital transdermal glyceryl trinitrate for ultra-acute ischaemic stroke: data from the RIGHT-2 randomised sham-controlled ambulance trial.
Appleton JP; Woodhouse LJ; Anderson CS; Ankolekar S; Cala L; Dixon M; England TJ; Krishnan K; Mair G; Muir KW; Potter J; Price CI; Randall M; Robinson TG; Roffe C; Sandset EC; Saver JL; Shone A; Siriwardena AN; Wardlaw JM; Sprigg N; Bath PM;
Stroke Vasc Neurol; 2024 Feb; 9(1):38-49. PubMed ID: 37290930
[TBL] [Abstract][Full Text] [Related]
7. Prehospital Transdermal Glyceryl Trinitrate for Ultra-Acute Intracerebral Hemorrhage: Data From the RIGHT-2 Trial.
Bath PM; Woodhouse LJ; Krishnan K; Appleton JP; Anderson CS; Berge E; Cala L; Dixon M; England TJ; Godolphin PJ; Hepburn T; Mair G; Montgomery AA; Phillips SJ; Potter J; Price CI; Randall M; Robinson TG; Roffe C; Rothwell PM; Sandset EC; Sanossian N; Saver JL; Siriwardena AN; Venables G; Wardlaw JM; Sprigg N
Stroke; 2019 Nov; 50(11):3064-3071. PubMed ID: 31587658
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824).
Ankolekar S; Fuller M; Cross I; Renton C; Cox P; Sprigg N; Siriwardena AN; Bath PM
Stroke; 2013 Nov; 44(11):3120-8. PubMed ID: 24003041
[TBL] [Abstract][Full Text] [Related]
9. Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial.
Olthuis SGH; Pirson FAV; Pinckaers FME; Hinsenveld WH; Nieboer D; Ceulemans A; Knapen RRMM; Robbe MMQ; Berkhemer OA; van Walderveen MAA; Lycklama À Nijeholt GJ; Uyttenboogaart M; Schonewille WJ; van der Sluijs PM; Wolff L; van Voorst H; Postma AA; Roosendaal SD; van der Hoorn A; Emmer BJ; Krietemeijer MGM; van Doormaal PJ; Roozenbeek B; Goldhoorn RB; Staals J; de Ridder IR; van der Leij C; Coutinho JM; van der Worp HB; Lo RTH; Bokkers RPH; van Dijk EI; Boogaarts HD; Wermer MJH; van Es ACGM; van Tuijl JH; Kortman HGJ; Gons RAR; Yo LSF; Vos JA; de Laat KF; van Dijk LC; van den Wijngaard IR; Hofmeijer J; Martens JM; Brouwers PJAM; Bulut T; Remmers MJM; de Jong TEAM; den Hertog HM; van Hasselt BAAM; Rozeman AD; Elgersma OEH; van der Veen B; Sudiono DR; Lingsma HF; Roos YBWEM; Majoie CBLM; van der Lugt A; Dippel DWJ; van Zwam WH; van Oostenbrugge RJ;
Lancet; 2023 Apr; 401(10385):1371-1380. PubMed ID: 37003289
[TBL] [Abstract][Full Text] [Related]
10. Time intervals and distances travelled for prehospital ambulance stroke care: data from the randomised-controlled ambulance-based Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2).
Dixon M; Appleton JP; Scutt P; Woodhouse LJ; Haywood LJ; Havard D; Williams J; Siriwardena AN; Bath PM;
BMJ Open; 2022 Nov; 12(11):e060211. PubMed ID: 36410799
[TBL] [Abstract][Full Text] [Related]
11. Benefits and safety of transdermal glyceryl trinitrate in acute stroke: a systematic review and meta-analysis of randomised trials (protocol).
Lim BL; Lee WF; Ng WM; Tay WL; Chan WL
BMJ Open; 2021 Jan; 11(1):e043591. PubMed ID: 33402412
[TBL] [Abstract][Full Text] [Related]
12. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial.
Woodhouse LJ; Appleton JP; Ankolekar S; England TJ; Mair G; Muir K; Price CI; Pocock S; Randall M; Robinson TG; Roffe C; Sandset EC; Saver JL; Siriwardena AN; Sprigg N; Wardlaw JM; Bath PM;
BMJ Neurol Open; 2023; 5(1):e000424. PubMed ID: 37564156
[TBL] [Abstract][Full Text] [Related]
13. It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis.
Appleton JP; Woodhouse LJ; Belcher A; Bereczki D; Berge E; Caso V; Chang HM; Christensen HK; Collins R; Gommans J; Laska AC; Ntaios G; Ozturk S; Sare GM; Szatmari S; Wang Y; Wardlaw JM; Sprigg N; Bath PM
Stroke Vasc Neurol; 2019 Mar; 4(1):28-35. PubMed ID: 31105976
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke.
Bath PM; Krishnan K; Appleton JP
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD000398. PubMed ID: 28429459
[TBL] [Abstract][Full Text] [Related]
15. Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands.
Huijberts I; Pinckaers FME; Olthuis SGH; van Kuijk SMJ; Postma AA; Boogaarts HD; Roos YBWEM; Majoie CBLM; van der Lugt A; Dippel DWJ; van Zwam WH; van Oostenbrugge RJ;
Lancet Neurol; 2024 Jun; ():. PubMed ID: 38909624
[TBL] [Abstract][Full Text] [Related]
16. Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis.
Krishnan K; Scutt P; Woodhouse L; Adami A; Becker JL; Berge E; Cala LA; Casado AM; Caso V; Chen C; Christensen H; Collins R; Czlonkowska A; Dineen RA; Gommans J; Koumellis P; Lees KR; Ntaios G; Ozturk S; Phillips SJ; Pocock SJ; de Silva A; Sprigg N; Szatmari S; Wardlaw JM; Bath PM
Stroke; 2016 Jan; 47(1):44-52. PubMed ID: 26645254
[TBL] [Abstract][Full Text] [Related]
17. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke.
Bath PM; Pathansali R; Iddenden R; Bath FJ
Cerebrovasc Dis; 2001; 11(3):265-72. PubMed ID: 11306778
[TBL] [Abstract][Full Text] [Related]
18. Transdermal delivery of glyceryl trinitrate: clinical applications in acute stroke.
Appleton JP; Krishnan K; Bath PM
Expert Opin Drug Deliv; 2020 Mar; 17(3):297-303. PubMed ID: 31973594
[No Abstract] [Full Text] [Related]
19. Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial.
Woodhouse L; Scutt P; Krishnan K; Berge E; Gommans J; Ntaios G; Wardlaw J; Sprigg N; Bath PM;
Stroke; 2015 Nov; 46(11):3194-201. PubMed ID: 26463698
[TBL] [Abstract][Full Text] [Related]
20. Benefits and safety of transdermal glyceryl trinitrate in acute stroke: A systematic review and meta-analysis of randomized trials.
Lim BL; Lee WF; Ng WM; Situ W; Loo KV; Man Goh CJ; Chan WL
Acad Emerg Med; 2022 Jun; 29(6):772-788. PubMed ID: 34741770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
